Pang Yan Ling Joy, Poruri Kiranmai, Martinis Susan A
Department of Biochemistry, University of Illinois at Urbana, Urbana, IL, USA.
Wiley Interdiscip Rev RNA. 2014 Jul-Aug;5(4):461-80. doi: 10.1002/wrna.1224. Epub 2014 Apr 4.
The aminoacyl-tRNA synthetases are prominently known for their classic function in the first step of protein synthesis, where they bear the responsibility of setting the genetic code. Each enzyme is exquisitely adapted to covalently link a single standard amino acid to its cognate set of tRNA isoacceptors. These ancient enzymes have evolved idiosyncratically to host alternate activities that go far beyond their aminoacylation role and impact a wide range of other metabolic pathways and cell signaling processes. The family of aminoacyl-tRNA synthetases has also been suggested as a remarkable scaffold to incorporate new domains that would drive evolution and the emergence of new organisms with more complex function. Because they are essential, the tRNA synthetases have served as pharmaceutical targets for drug and antibiotic development. The recent unfolding of novel important functions for this family of proteins offers new and promising pathways for therapeutic development to treat diverse human diseases.
氨酰-tRNA合成酶以其在蛋白质合成第一步中的经典功能而闻名,在这一步中它们负责确定遗传密码。每种酶都经过精心调整,以将单个标准氨基酸共价连接到其对应的一组tRNA同工受体上。这些古老的酶已经特异地进化,以承担超出其氨酰化作用的其他活动,并影响广泛的其他代谢途径和细胞信号传导过程。氨酰-tRNA合成酶家族也被认为是一个卓越的支架,可纳入新的结构域,从而推动进化以及具有更复杂功能的新生物体的出现。由于它们至关重要,tRNA合成酶已成为药物和抗生素开发的药物靶点。该蛋白质家族最近展现出的新的重要功能为治疗多种人类疾病的治疗发展提供了新的、有前景的途径。